Therefore, decreased leucocyte activation in infected CCR2−/− mice may explain the decreased cytokine storm and decreased tissue damage observed in these animals. The CCR4 receptor shown to be relevant for virus-induced liver damage and the associated

systemic inflammation in the present model. We also found that CCL17/TARC, one of the ligands for CCR4, was detectable at high levels in the spleen of infected mice. Viral load was not altered in CCR4−/− when compared with WT animals, which suggest that that CCR4 does not play a major role in the control of viral entry and replication, but contribute mostly to the cascade of events that lead to tissue and systemic damage. Interestingly, Ruxolitinib concentration CCR4 deficiency is associated with attenuated severity of murine polymicrobial sepsis and lipopolysaccharide-induced endotoxic shock, implicating Selleckchem Dabrafenib this receptor in the pathogenesis of acute conditions.[88, 89] Other experiments, however, have found a protective role for CCL22/MDC, a CCR4 ligand, in a caecal ligation and puncture model of sepsis in mice.[90] It is difficult to suggest the cellular and molecular mechanisms by which CCR4 may contribute to the pathogenesis of dengue. However, CCR4 may be important for the trafficking and activation

of NKT/invariant NKT (iNKT) cells and naive CD8+ cells by at least two independent chemokine pathways, including CCL17/TARC and CCL22.[91, 92] Moreover, pulmonary localization of iNKT cells is critical for the induction of airway hyperreactivity and requires CCR4 expression by iNKT cells.[93] In fact, excessive NKT/iNKT activation contributes to the pathogenesis of severe disease in our model.[70] Our studies suggest that the chemokine storm that follows severe primary DENV infection is associated with the development of inflammation rather than protection against severe disease. Hence, blockade of the chemokine system may be beneficial as co-adjuvant treatment for severe DENV infection and might be further explored. A summary of the role of CC chemokines and their receptors

in DENV infection is shown in Table 2. The NKT cells constitute a heterogeneous population of non-conventional Glycogen branching enzyme αβ T lymphocytes that recognize self and foreign (glyco) lipid antigens through their T-cell receptors (TCRs). NKT TCR-mediated responses are restricted by CD1d, a member of the non-polymorphic CD1 antigen-presenting protein family that promotes the presentation of endogenous and pathogen-derived lipid antigens to the TCR.[94-96] CD1d-restricted NKT cells are divided into invariant (iNKT cells, or type I NKT cells), the predominant subset which express an invariant TCR-α chain (Vα14Jα18 in mice), and variant (vNKT cells, or non-invariant or type II NKT cells), which express more diverse TCRs.[94, 95] Invariant NKT cells have regulatory functions in autoimmune and inflammatory diseases, cancer and infection.